The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: alkeran     Quarter: 2016Q3

Total Drug/Injury Combinations: 109     Number of Pages: 6

DRUGNAME PT EventCount
ALKERAN International normalised ratio increased 1 view events
ALKERAN Interstitial lung disease 1 view events
ALKERAN Intestinal obstruction 1 view events
ALKERAN Liver disorder 1 view events
ALKERAN Lung disorder 1 view events
ALKERAN Lung infiltration 1 view events
ALKERAN Lymphoma 1 view events
ALKERAN Meningioma 1 view events
ALKERAN Multiple organ dysfunction syndrome 1 view events
ALKERAN Myelodysplastic syndrome 1 view events
ALKERAN Neutropenic colitis 1 view events
ALKERAN Peripheral sensory neuropathy 1 view events
ALKERAN Pinealoblastoma 1 view events
ALKERAN Plasma cell myeloma 1 view events
ALKERAN Pleural effusion 1 view events
ALKERAN Primary hypothyroidism 1 view events
ALKERAN Primary myelofibrosis 1 view events
ALKERAN Product use issue 1 view events
ALKERAN Pulmonary congestion 1 view events
ALKERAN Rash erythematous 1 view events

Total Drug/Injury Combinations: 109     Number of Pages: 6

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)